newsfilter
← Latest News
FDA Press Releases·

FDA Roundup: May 7, 2024

Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA announced a meeting of the Psychopharmacologic Drugs Advisory Committee on June 4 to discuss a new drug application for midomafetamine (MDMA) capsules, submitted by Lykos Therapeutics, for the treatment of post-traumatic stress disorder. The committee will discuss the overall benefit-risk profile of the product, including the potential public health impact. The FDA and invited participants may attend the meeting in-person at the FDA White Oak Campus. The public will have the option to participate via an online teleconferencing and/or video conferencing platform (Zoo...